HealthCor Management’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

HealthCor Management’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-425,000	Closed	-$21.3M	–	86
2015 Q1	$21.3M	Buy	425,000 +333,400	+364%	+$14M	1.02%	38
2014 Q4	$3.18M	Buy	+91,600	New	+$3.2M	0.18%	45
2014 Q3	–	Sell	-53,800	Closed	-$2.06M	–	63
2014 Q2	$2.06M	Buy	+53,800	New	+$1.88M	0.1%	49

Other funds holding KYTH

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

HealthCor Management's KYTH Position: Q2 2015 in Review

HealthCor Management sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q2 2015, closing a stake of 425,000 shares — an estimated $21.3M sold.

HealthCor Management first reported a position in KYTH in Q2 2014 and held it in 3 quarters. The position peaked at $21.3M in Q1 2015. 153 funds tracked by Wall St. Rank hold KYTH as of Q2 2015.

HealthCor Management reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q2 2015 after selling out during the quarter.
HealthCor Management sold 425,000 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q2 2015, an estimated $21.3M.
HealthCor Management first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q2 2014 and held it in 3 quarters.
HealthCor Management's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $21.3M in Q1 2015.
153 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q2 2015.

Based on HealthCor Management's 13F filing for Q2 2015, filed 14 Aug 2015.